Alliance for Clinical Trials in Oncology
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Genetic: reverse transcriptase-polymerase chain reactionOther: immunohistochemistry staining method
- First Posted Date
- 2003-08-13
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 501
- Registration Number
- NCT00003006
- Locations
- πΊπΈ
Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States
πΊπΈMemorial Sloan-Kettering Cancer Center, New York, New York, United States
πΊπΈBarnes-Jewish Hospital, Saint Louis, Missouri, United States
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
- Conditions
- Carcinoma of Unknown Primary
- Interventions
- First Posted Date
- 2003-08-07
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 31
- Registration Number
- NCT00066781
- Locations
- πΊπΈ
Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States
πΊπΈMercy Cancer Center at Mercy Medical Center - North Iowa, Mason City, Iowa, United States
πΊπΈMayo Clinic Cancer Center, Rochester, Minnesota, United States
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
- Conditions
- AnorexiaCachexia
- Interventions
- First Posted Date
- 2003-08-05
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 429
- Registration Number
- NCT00031707
- Locations
- π¨π¦
Queen Elizabeth Hospital, PEI, Charlottetown, Prince Edward Island, Canada
π¨π¦Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada
πΊπΈSiouxland Hematology-Oncology, Sioux City, Iowa, United States
Gene Testing in Patients With Colon Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Genetic: mutation analysisGenetic: tumor replication error analysis
- First Posted Date
- 2003-07-15
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 300
- Registration Number
- NCT00003571
- Locations
- πΊπΈ
CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
πΊπΈUniversity of California San Diego Cancer Center, La Jolla, California, United States
πΊπΈLombardi Cancer Center, Washington, District of Columbia, United States
Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer
- Conditions
- Metastatic CancerColorectal Cancer
- Interventions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 94
- Registration Number
- NCT00063960
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
πΊπΈUniversity Medical Group, Providence, Rhode Island, United States
πΊπΈUniversity of Minnesota Cancer Center, Minneapolis, Minnesota, United States
Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2003-06-30
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 27
- Registration Number
- NCT00028925
- Locations
- πΊπΈ
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
πΊπΈCCOP - Duluth, Duluth, Minnesota, United States
πΊπΈCCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2003-06-17
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 58
- Registration Number
- NCT00027612
Combination Chemotherapy in Treating Patients With Bladder Cancer
- Conditions
- Bladder Cancer
- Interventions
- First Posted Date
- 2003-06-10
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 42
- Registration Number
- NCT00014534
- Locations
- πΊπΈ
Geisinger Medical Group, State College, Pennsylvania, United States
πΊπΈWilliam N. Wishard Memorial Hospital, Indianapolis, Indiana, United States
πΊπΈRebecca and John Moores UCSD Cancer Center, San Diego, California, United States
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2016-12-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 65
- Registration Number
- NCT00062062
- Locations
- πΊπΈ
Promedica Cancer Center at Flower Hospital, Sylvania, Ohio, United States
πΊπΈMedical College of Ohio Cancer Institute, Toledo, Ohio, United States
πΊπΈSt. Vincent Mercy Medical Center, Toledo, Ohio, United States
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabRadiation: yttrium Y 90 ibritumomab tiuxetan
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 84
- Registration Number
- NCT00062114
- Locations
- πΊπΈ
Billings Clinic Cancer Center, Billings, Montana, United States
πΊπΈCCOP - Montana Cancer Consortium, Billings, Montana, United States
πΊπΈBeebe Medical Center, Lewes, Delaware, United States